CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-27 | Freitag Gregory Gene Director | Grant or award | +2,300 | 249,261 | ||
| 2020-12-27 | MARIANI PETER J Chief Financial Officer | Grant or award | +5,250 | 11,669 | ||
| 2020-12-27 | Scopelianos Angelo VP Research & Development | Grant or award | +2,300 | 6,096 | ||
| 2020-12-27 | Zaderej Karen L. CEO | Grant or award | +8,800 | 677,599 | ||
| 2020-12-27 | Friedman Mark Louis VP,Regulatory & Quality | Grant or award | +2,300 | 11,691 | ||
| 2020-12-27 | MARTINEZ MARIA D. Chief Human Resources Officer | Grant or award | +2,300 | 5,232 | ||
| 2020-12-27 | Billet Isabelle Chief Strategy and BD Officer | Grant or award | +2,300 | 10,145 | ||
| 2020-12-23 | Zaderej Karen L. CEO | Option exercise | +19,375 | $4.81 | $93K | 666,094 |
| 2020-12-23 | Zaderej Karen L. CEO | Option exercise · Employee Stock Option (right to buy) | −19,375 | 0 | ||
| 2020-12-22 | Donovan Michael Patrick VP Operations | Sale | −279 | $17.19 | $5K | 26,029 |
| 2020-12-21 | Zaderej Karen L. CEO | Sale | −1,275 | $16.42 | $21K | 646,719 |
| 2020-12-21 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Sale | −147 | $16.42 | $2K | 62,111 |
| 2020-12-21 | Freitag Gregory Gene Director | Sale | −379 | $16.42 | $6K | 245,076 |
| 2020-12-21 | Donovan Michael Patrick VP Operations | Sale | −96 | $16.42 | $2K | 26,308 |
| 2020-12-21 | MARIANI PETER J Chief Financial Officer | Sale | −481 | $16.42 | $8K | 6,419 |
| 2020-12-21 | Friedman Mark Louis VP,Regulatory & Quality | Sale | −96 | $16.42 | $2K | 8,893 |
| 2020-12-18 | Zaderej Karen L. CEO | Grant or award | +3,125 | 647,994 | ||
| 2020-12-18 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Grant or award | +575 | 62,258 | ||
| 2020-12-18 | Freitag Gregory Gene Director | Grant or award | +925 | 245,455 | ||
| 2020-12-18 | Donovan Michael Patrick VP Operations | Grant or award | +375 | 26,404 |
Page 40 of 69 · 1,376 trades